fashion -WSS

fashion

author：comprehensive 2025-09-28 21:58:15 - browse：92

Anthony Fernandez holds a Wegovy injection, the ALP-1 agonist medication he uses to help curb his food cravings – Obesity medication and science coverage for STAT — A person holds a Wegovy injection pen. Kayana Szymczak for STAT

Medicare confirmed this week that it will cover Novo Nordisk’s obesity drug Wegovy if prescribed to prevent heart problems, but policy experts said Medicare patients are still likely to encounter significant barriers getting access to the highly popular and expensive drug.

Medicare previously wasn’t reimbursing for Wegovy, since the federal payer is legally barred from covering weight loss drugs. But the Food and Drug Administration this month approved Wegovy for preventing heart problems in people with obesity and heart disease, leading many to suspect that Medicare would start covering the drug for this usage.

Makers of obesity drugs have been hoping that showing additional benefits beyond weight loss would induce more insurers to cover them. Medicare’s guidance, first reported Thursday, moves in that direction, but experts point out that the private insurers that administer Medicare’s prescription drug benefit — called Part D — can still choose to not include Wegovy on their formularies, especially if they think it would be too costly.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Researchers CRISPR chickens in bid to protect them from bird flu

hotspot

WSS

How clinical AI models' predictive power can degrade over time

European regulators recommend Amylyx's ALS drug be rejected

A fraught question for the kids of Alzheimer’s: Is it coming for us?

Apple Watch's A

STAT Readout: Today's biotech news includes Sana and Amylyx

Better Therapeutics data on benefit with GLP

hotspot

fashion

entertainment

What does generative AI mean for health care? We asked experts

Sanofi strikes deal with Novavax, boosting the vaccine maker

How one medical school became remarkably diverse

H5N1 bird flu: what we're starting to learn about infection in cows

Peter Hotez and the public health issue of online harassment

Better Therapeutics data on benefit with GLP

United colonoscopy coverage change 'may cost lives,' doctors say

Software glitch causes Tandem insulin pump to shutdown, FDA warns

New air purifier tech could be key to improving indoor air quality

STAT Readout: Today's biotech news includes Sana and Amylyx

focus

Researchers CRISPR chickens in bid to protect them from bird flu

Making AI in medicine accessible to smaller, and rural hospitals

Female surgeons have lower rates of long

H5N1 bird flu: what we're starting to learn about infection in cows

Dairy farmers resist CDC push for PPE against bird flu virus

A fraught question for the kids of Alzheimer’s: Is it coming for us?

hotspot

explore

focus

Wikipedia